| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.3M | — | +0.0% |
| R&D Expense | $20.4M | -7.7% | +72.4% |
| SG&A Expense | $5.9M | +4.5% | +71.1% |
| Operating Income | -$26.3M | +5.2% | -102.0% |
| Net Income | -$24.6M | +5.2% | -95.7% |
| EPS (Basic) | -$0.54 | +5.3% | -42.1% |
| EPS (Diluted) | -$0.54 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $19.5M | -16.1% | -71.5% |
| Short-term Investments | $79.1M | -20.6% | +374.8% |
| Current Assets | $101.0M | -18.7% | +17.6% |
| Total Assets | $126.4M | -5.3% | +36.0% |
| Current Liabilities | $28.1M | -0.9% | +37.5% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$46.2M | — | — |
| Capital Expenditures | $1.2M | — | — |
| Investing Cash Flow | $54.4M | — | — |
| Financing Cash Flow | $77K | — | — |
| Free Cash Flow | -$47.5M | — | — |
| -42.1% |
| $42.6M |
| +48.9% |
| +72.4% |
| Stockholders' Equity | $83.9M | -20.1% | +22.9% |